News

RedHill Biopharma Reports Financial Results for the First Quarter of 2013

Published on May 2, 2013 in News.

RedHill Biopharma Reports Financial Results for the First Quarter of 2013 (May 2 2013) RedHill Biopharma Reports Financial Results for the First Quarter of 2013 (May 2 2013) – Hebrew

RedHill Biopharma Submits NDA for U.S. Marketing of RHB-103 Anti-Migraine Oral Thin Film

Published on March 27, 2013 in News.

RedHill Biopharma Submits NDA for U S Marketing of RHB-103 Anti-Migraine Oral Thin Film RedHill Biopharma Submits NDA for U S Marketing of RHB-103 Anti-Migraine Oral Thin Film – Hebrew

RedHill Biopharma Provides Update on RHB-101 (Cardio) Scientific Advice Meeting and Planned Marketing Application Submission in Europe

Published on March 19, 2013 in News.

RedHill Biopharma Provides Update on RHB-101 (Cardio) Scientific Advice Meeting and Planned Marketing Application Submission in Europe RedHill Biopharma Provides Update on RHB-101 (Cardio) Scientific Advice Meeting and Planned Marketing Application Submission in Europe – Hebrew

RedHill Biopharma to Present at the 25th Annual ROTH Conference – March 19 2013

Published on March 6, 2013 in News.

RedHill Biopharma to Present at the 25th Annual ROTH Conference – March 19 2013

RedHill Biopharma Provides Update on Development Progress and Planned NDA Submission for RHB-102 (oncology support, anti-emetic)

Published on February 25, 2013 in News.

RedHill Biopharma Provides Update on Development Progress and Planned NDA Submission for RHB-102 (Feb 25 2013) – Hebrew RedHill Biopharma Provides Update on Development Progress and Planned NDA Submission for RHB-102 (Feb 25 2013)

RedHill Biopharma reports 2012 fourth quarter and year-end results

Published on February 19, 2013 in News.

RedHill Biopharma Reports 2012 Fourth Quarter and Year-End Results (February 19 2013)- Hebrew RedHill Biopharma Reports 2012 Fourth Quarter and Year-End Results (February 19 2013)

RedHill announces Notice of Allowance for US patent application relating to RHB-101 (Cardio)

Published on February 19, 2013 in News.

RedHill Announces Notice of Allowance for US patent application – RHB-101 (Cardio)

RedHill announces new patent and provides update on RHB-104 (Crohn’s)

Published on January 7, 2013 in News.

RedHill announces new patent and provides update on RHB-104 (Crohn’s) RedHill announces new patent and provides update on RHB-104 (Crohn’s) – Hebrew

RedHill announces NASDAQ listing and trading under the ticker “RDHL”

Published on December 27, 2012 in News.

RedHill to commence NASDAQ listing and trading today under the ticker “RDHL” RedHill to commence NASDAQ listing and trading today under the ticker “RDHL” (Hebrew)

RedHill announces successful completion of a private placement of approximately $6.5 million

Published on December 10, 2012 in News.

RedHill Biopharma Announces Successful Completion of $6.5 Million Private Placement RedHill Biopharma Announces Successful Completion of $6.5 Million Private Placement (Hebrew)